We serve Chemical Name:2-(triazol-1-yl)ethanamine CAS:4320-98-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(triazol-1-yl)ethanamine
CAS.NO:4320-98-3
Synonyms:N2-<2-Amino-aethyl>-1,2,3-triazol
Molecular Formula:C4H8N4
Molecular Weight:112.13300
HS Code:
Physical and Chemical Properties:
Melting point:129-131ºC
Boiling point:241ºC
Density:1.31
Index of Refraction:
PSA:56.73000
Exact Mass:112.07500
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N2-< chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,-1,2,3-triazol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N2-< Use and application,-1,2,3-triazol technical grade,usp/ep/jp grade.
Related News: Nearly all patients who got the vaccine developed antibodies designed to head off the spread of abnormal tau while leaving healthy tau proteins intact, Novak said. 2-(triazol-1-yl)ethanamine manufacturer Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies. 2-(triazol-1-yl)ethanamine supplier The Company��s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. 2-(triazol-1-yl)ethanamine vendor Retrogenix��s proprietary cell microarray technology provides a fast, accurate and effective solution for determining the primary target and secondary target (off-target) activities of antibodies, proteins, cell therapies, small molecules and viruses. 2-(triazol-1-yl)ethanamine factory Nearly all patients who got the vaccine developed antibodies designed to head off the spread of abnormal tau while leaving healthy tau proteins intact, Novak said.
